Bliss GVS Pharma Ltd Half Yearly Results

Gross Sales

408.4

401.32

398.85

371.4

390.5

Excise Duty

0

0

0

0

0

Net Sales

408.4

401.32

398.85

371.4

390.5

Other Operating Income

0

0

0

0

0

Other Income

27.33

9.16

11.02

17.72

8.62

Total Income

435.74

410.48

409.87

389.11

399.12

Total Expenditure

357.53

325.51

356

292.82

336.57

PBIDT

78.21

84.97

53.87

96.3

62.55

Interest

2.76

5.36

3.97

2.94

6.35

PBDT

75.45

79.61

49.9

93.36

56.21

Depreciation

15.59

13.83

13.8

12.58

9.52

Minority Interest Before NP

0

0

0

0

0

Tax

19.65

19.72

16.18

17.08

19.34

Deferred Tax

-2.25

-1.74

-4.25

6.28

-5.91

Reported Profit After Tax

42.46

47.8

24.16

57.42

33.25

Minority Interest After NP

3.11

2.84

5.7

0.43

1.97

Net Profit after Minority Interest

39.34

44.96

18.46

56.99

31.29

Extra-ordinary Items

0

0

-29.2

0

0

Adjusted Profit After Extra-ordinary item

39.34

44.96

47.66

56.99

31.29

EPS (Unit Curr.)

3.73

4.28

1.76

5.47

3

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

10.54

10.51

10.47

10.44

10.42

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

19.15

21.17

13.5

25.92

16.01

PBDTM(%)

-

-

-

-

-

PATM(%)

10.39

11.91

6.05

15.46

8.51